Formulation,in vitroandin vivoevaluation of transdermal patches containing risperidone
Authors:
- 16 February 2012
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 39 (1) , 39-50
Abstract
The efficacy of oral risperidone treatment in prevention of schizophrenia is well known. However, oral side effects and patient compliance is always a problem for schizophrenics. In this study, risperidone was formulated into matrix transdermal patches to overcome these problems. The formulation factors for such patches, including eudragit RL 100 and eudragit RS 100 as matrix forming polymers, olive oil, groundnut oil and jojoba oil in different concentrations as enhancers and amount of drug loaded were investigated. The transdermal patches containing risperidone were prepared by solvent casting method and characterized for physicochemical and in vitro permeation studies through excised rat skin. Among the tested preparations, formulations with 20% risperidone, 3:2 ERL 100 and ERS 100 as polymers, mixture of olive oil and jojoba oil as enhancer, exhibited greatest cumulative amount of drug permeated (1.87 ± 0.09 mg/cm2) in 72 h, so batch ROJ was concluded as optimized formulation and assessed for pharmacokinetic, pharmacodynamic and skin irritation potential. The pharmacokinetic characteristics of the optimized risperidone patch were determined using rabbits, while orally administered risperidone in solution was used for comparison. The calculated relative bioavailability of risperidone transdermal patch was 115.20% with prolonged release of drug. Neuroleptic efficacy of transdermal formulation was assessed by rota-rod and grip test in comparison with control and marketed oral formulations with no skin irritation. This suggests the transdermal application of risperidone holds promise for improved bioavailability and better management of schizophrenia in long-term basis.Keywords
This publication has 28 references indexed in Scilit:
- Eudragit-based transdermal delivery system of pentazocine: Physico-chemical, in vitro and in vivo evaluationsPharmaceutical Development and Technology, 2010
- Design of Meloxicam and Lornoxicam Transdermal Patches: Preparation, Physical Characterization, ex Vivo and in Vivo StudiesChemical and Pharmaceutical Bulletin, 2010
- In Vitro and In Vivo Assessment of Matrix Type Transdermal Therapeutic System of Labetalol HydrochlorideCurrent Drug Delivery, 2009
- Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oilColloids and Surfaces B: Biointerfaces, 2008
- Basil Oil is a Promising Skin Penetration Enhancer for Transdermal Delivery of Labetolol HydrochlorideDrug Development and Industrial Pharmacy, 2008
- Drug delivery systems improve Pharmaceutical profile and facilitate medication adherenceAdvances in Therapy, 2005
- A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviorsSchizophrenia Research, 2005
- Arterial Stiffness and Stroke in HypertensionCNS Drugs, 2005
- Permeation Enhancers for Transdermal Drug DeliveryDrug Development and Industrial Pharmacy, 2000
- Editorial: Recent Developments in Atypical Antipsychotic MedicationsSchizophrenia Bulletin, 1998